FDAnews
www.fdanews.com/articles/174904-oculus-garners-ce-mark-for-mucoclyns

Oculus Garners CE Mark for MucoClyns

January 14, 2016

Oculus Innovative Sciences has scooped up the CE mark for its MucoClyns for the treatment of wounds.

A Microcyn-based solution developed through the electrochemical treatment of dilute saltwater, MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces following an unexpected exposure to infection risk and before receiving professional medical treatment.

The company is in discussions with potential partners for the distribution of the solution in Europe. — Michael Cipriano